In a report released yesterday, Mayank Mamtani from B.Riley Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), ...

B. Riley analyst Yuan Zhi reiterates a Buy rating on Mirion (MIR) amid concerns regarding DeepSeek. Over the weekend, reported said China’s ...

B. Riley Financial Inc. received more demands for information from federal regulators about its dealings with now-bankrupt ...

B. Riley Financial Inc. suspended dividends on a pair of its preferred shares, holding off on cash payments to some investors ...

I have covered B. Riley Financial, Inc. or "B. Riley" (NASDAQ:RILY, NASDAQ:RILYL, NASDAQ:RILYP, NASDAQ:RILYM, NASDAQ:RILYK, NASDAQ:RILYN, NASDAQ:RILYG, NASDAQ:RILYT ...

Redwire Corp (NYSE:RDW) was upgraded to Buy from Neutral at financial services company B. Riley, which also hiked its price ...

LOS ANGELES, Jan. 21, 2025 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Company"), a diversified financial services company, today ...

The deferral affects B. Riley’s 6.875% Series A and 7.375% Series B preferred stock, according to a statement Monday. Dividends on those preferreds cost the company $2 million in the second ...

B. Riley Securities maintained its Buy ratings on Rigetti and D-Wave Quantum and raised price targets noting that some commercialization concerns are misplaced.